EMEA (Europe, Middle East and Africa) Nuclear Medicine/Radiopharmaceutic Market Report 2017

October 2017 | 112 pages | ID: E4D45F4C731EN
QYResearch

Abstracts

In this report, the EMEA Nuclear Medicine/Radiopharmaceutic market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (MT), revenue (Million USD), market share and growth rate of Nuclear Medicine/Radiopharmaceutic for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Nuclear Medicine/Radiopharmaceutic market competition by top manufacturers/players, with Nuclear Medicine/Radiopharmaceutic sales volume (MT), price (USD/Kg), revenue (Million USD) and market share for each manufacturer/player; the top players including

• China Isotope Radiation
• Dongcheng
• Jaco
• Ciaeriar
• Advanced Molecular-imaging Solution
• Shanghai Atom Kexing
• Cardinal Health
• Mallinckrodt
• GE Healthcare
• Lantheus Medical Imaging
• Bayer Healthcare
• Bracco Imaging
• Eczacibasi-Monrol Nuclear Products
• Nordion
• Advanced Accelerator Applications
• Iba Molecular Imaging

On the basis of product, this report displays the sales volume (MT), revenue (Million USD), product price (USD/Kg), market share and growth rate of each type, primarily split into

• Diagnostic
• Therapeutic

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (MT), market share and growth rate of Nuclear Medicine/Radiopharmaceutic for each application, including

• Oncology
• Thyroid
• Cardiology
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Nuclear Medicine/Radiopharmaceutic Market Report 2017

1 NUCLEAR MEDICINE/RADIOPHARMACEUTIC OVERVIEW

1.1 Product Overview and Scope of Nuclear Medicine/Radiopharmaceutic
1.2 Classification of Nuclear Medicine/Radiopharmaceutic
  1.2.1 EMEA Nuclear Medicine/Radiopharmaceutic Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Nuclear Medicine/Radiopharmaceutic Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Diagnostic
  1.2.4 Therapeutic
1.3 EMEA Nuclear Medicine/Radiopharmaceutic Market by Application/End Users
  1.3.1 EMEA Nuclear Medicine/Radiopharmaceutic Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Oncology
  1.3.3 Thyroid
  1.3.4 Cardiology
  1.3.5 Others
1.4 EMEA Nuclear Medicine/Radiopharmaceutic Market by Region
  1.4.1 EMEA Nuclear Medicine/Radiopharmaceutic Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Nuclear Medicine/Radiopharmaceutic (2012-2022)
  1.5.1 EMEA Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2012-2022)

2 EMEA NUCLEAR MEDICINE/RADIOPHARMACEUTIC COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Nuclear Medicine/Radiopharmaceutic Market Competition by Players/Manufacturers
  2.1.1 EMEA Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Nuclear Medicine/Radiopharmaceutic Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Nuclear Medicine/Radiopharmaceutic Sale Price by Players (2012-2017)
2.2 EMEA Nuclear Medicine/Radiopharmaceutic (Volume and Value) by Type/Product Category
  2.2.1 EMEA Nuclear Medicine/Radiopharmaceutic Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Nuclear Medicine/Radiopharmaceutic Sale Price by Type (2012-2017)
2.3 EMEA Nuclear Medicine/Radiopharmaceutic (Volume) by Application
2.4 EMEA Nuclear Medicine/Radiopharmaceutic (Volume and Value) by Region
  2.4.1 EMEA Nuclear Medicine/Radiopharmaceutic Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Nuclear Medicine/Radiopharmaceutic Sales Price by Region (2012-2017)

3 EUROPE NUCLEAR MEDICINE/RADIOPHARMACEUTIC (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Nuclear Medicine/Radiopharmaceutic Sales and Value (2012-2017)
  3.1.1 Europe Nuclear Medicine/Radiopharmaceutic Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2012-2017)
3.2 Europe Nuclear Medicine/Radiopharmaceutic Sales and Market Share by Type
3.3 Europe Nuclear Medicine/Radiopharmaceutic Sales and Market Share by Application
3.4 Europe Nuclear Medicine/Radiopharmaceutic Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Nuclear Medicine/Radiopharmaceutic Sales Volume by Countries (2012-2017)
  3.4.2 Europe Nuclear Medicine/Radiopharmaceutic Revenue by Countries (2012-2017)
  3.4.3 Germany Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2012-2017)
  3.4.4 France Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2012-2017)
  3.4.5 UK Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2012-2017)
  3.4.6 Russia Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2012-2017)
  3.4.7 Italy Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2012-2017)

4 MIDDLE EAST NUCLEAR MEDICINE/RADIOPHARMACEUTIC (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Nuclear Medicine/Radiopharmaceutic Sales and Value (2012-2017)
  4.1.1 Middle East Nuclear Medicine/Radiopharmaceutic Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2012-2017)
4.2 Middle East Nuclear Medicine/Radiopharmaceutic Sales and Market Share by Type
4.3 Middle East Nuclear Medicine/Radiopharmaceutic Sales and Market Share by Application
4.4 Middle East Nuclear Medicine/Radiopharmaceutic Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Nuclear Medicine/Radiopharmaceutic Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Nuclear Medicine/Radiopharmaceutic Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2012-2017)
  4.4.4 Israel Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2012-2017)
  4.4.5 UAE Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2012-2017)
  4.4.6 Iran Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2012-2017)

5 AFRICA NUCLEAR MEDICINE/RADIOPHARMACEUTIC (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Nuclear Medicine/Radiopharmaceutic Sales and Value (2012-2017)
  5.1.1 Africa Nuclear Medicine/Radiopharmaceutic Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2012-2017)
5.2 Africa Nuclear Medicine/Radiopharmaceutic Sales and Market Share by Type
5.3 Africa Nuclear Medicine/Radiopharmaceutic Sales and Market Share by Application
5.4 Africa Nuclear Medicine/Radiopharmaceutic Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Nuclear Medicine/Radiopharmaceutic Sales Volume by Countries (2012-2017)
  5.4.2 Africa Nuclear Medicine/Radiopharmaceutic Revenue by Countries (2012-2017)
  5.4.3 South Africa Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2012-2017)

6 EMEA NUCLEAR MEDICINE/RADIOPHARMACEUTIC MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 China Isotope Radiation
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Nuclear Medicine/Radiopharmaceutic Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 China Isotope Radiation Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Dongcheng
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Nuclear Medicine/Radiopharmaceutic Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Dongcheng Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Jaco
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Nuclear Medicine/Radiopharmaceutic Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Jaco Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Ciaeriar
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Nuclear Medicine/Radiopharmaceutic Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Ciaeriar Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Advanced Molecular-imaging Solution
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Nuclear Medicine/Radiopharmaceutic Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Shanghai Atom Kexing
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Nuclear Medicine/Radiopharmaceutic Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Cardinal Health
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Nuclear Medicine/Radiopharmaceutic Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Cardinal Health Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Mallinckrodt
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Nuclear Medicine/Radiopharmaceutic Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 GE Healthcare
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Nuclear Medicine/Radiopharmaceutic Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Lantheus Medical Imaging
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Nuclear Medicine/Radiopharmaceutic Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Bayer Healthcare
6.12 Bracco Imaging
6.13 Eczacibasi-Monrol Nuclear Products
6.14 Nordion
6.15 Advanced Accelerator Applications
6.16 Iba Molecular Imaging

7 NUCLEAR MEDICINE/RADIOPHARMACEUTIC MANUFACTURING COST ANALYSIS

7.1 Nuclear Medicine/Radiopharmaceutic Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceutic

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Nuclear Medicine/Radiopharmaceutic Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Nuclear Medicine/Radiopharmaceutic Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA NUCLEAR MEDICINE/RADIOPHARMACEUTIC MARKET FORECAST (2017-2022)

11.1 EMEA Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Nuclear Medicine/Radiopharmaceutic Price and Trend Forecast (2017-2022)
11.2 EMEA Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Nuclear Medicine/Radiopharmaceutic Sales Forecast by Type (2017-2022)
11.7 EMEA Nuclear Medicine/Radiopharmaceutic Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Nuclear Medicine/Radiopharmaceutic
Figure EMEA Nuclear Medicine/Radiopharmaceutic Sales Volume (MT) by Type (2012-2022)
Figure EMEA Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type (Product Category) in 2016
Figure Diagnostic Product Picture
Figure Therapeutic Product Picture
Figure EMEA Nuclear Medicine/Radiopharmaceutic Sales Volume (MT) by Application (2012-2022)
Figure EMEA Sales Market Share of Nuclear Medicine/Radiopharmaceutic by Application in 2016
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Thyroid Examples
Table Key Downstream Customer in Thyroid
Figure Cardiology Examples
Table Key Downstream Customer in Cardiology
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Nuclear Medicine/Radiopharmaceutic Market Size (Million USD) by Region (2012-2022)
Figure Europe Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) Status and Forecast by Countries
Figure Africa Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Nuclear Medicine/Radiopharmaceutic Sales Volume and Growth Rate (2012-2022)
Figure EMEA Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Nuclear Medicine/Radiopharmaceutic Market Major Players Product Sales Volume (MT) (2012-2017)
Table EMEA Nuclear Medicine/Radiopharmaceutic Sales Volume (MT) of Major Players (2012-2017)
Table EMEA Nuclear Medicine/Radiopharmaceutic Sales Share by Players (2012-2017)
Figure 2016 Nuclear Medicine/Radiopharmaceutic Sales Share by Players
Figure 2017 Nuclear Medicine/Radiopharmaceutic Sales Share by Players
Figure EMEA Nuclear Medicine/Radiopharmaceutic Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) by Players (2012-2017)
Table EMEA Nuclear Medicine/Radiopharmaceutic Revenue Share by Players (2012-2017)
Table 2016 EMEA Nuclear Medicine/Radiopharmaceutic Revenue Share by Players
Table 2017 EMEA Nuclear Medicine/Radiopharmaceutic Revenue Share by Players
Table EMEA Nuclear Medicine/Radiopharmaceutic Sale Price (USD/Kg) by Players (2012-2017)
Table EMEA Nuclear Medicine/Radiopharmaceutic Sales (MT) and Market Share by Type (2012-2017)
Table EMEA Nuclear Medicine/Radiopharmaceutic Sales Share by Type (2012-2017)
Figure Sales Market Share of Nuclear Medicine/Radiopharmaceutic by Type (2012-2017)
Figure EMEA Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2012-2017)
Table EMEA Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Nuclear Medicine/Radiopharmaceutic Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Nuclear Medicine/Radiopharmaceutic by Type in 2016
Table EMEA Nuclear Medicine/Radiopharmaceutic Sale Price (USD/Kg) by Type (2012-2017)
Table EMEA Nuclear Medicine/Radiopharmaceutic Sales (MT) and Market Share by Application (2012-2017)
Table EMEA Nuclear Medicine/Radiopharmaceutic Sales Share by Application (2012-2017)
Figure Sales Market Share of Nuclear Medicine/Radiopharmaceutic by Application (2012-2017)
Figure EMEA Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application in 2016
Table EMEA Nuclear Medicine/Radiopharmaceutic Sales (MT) and Market Share by Region (2012-2017)
Table EMEA Nuclear Medicine/Radiopharmaceutic Sales Share by Region (2012-2017)
Figure Sales Market Share of Nuclear Medicine/Radiopharmaceutic by Region (2012-2017)
Figure EMEA Nuclear Medicine/Radiopharmaceutic Sales Market Share in 2016
Table EMEA Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Nuclear Medicine/Radiopharmaceutic Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Nuclear Medicine/Radiopharmaceutic by Region (2012-2017)
Figure EMEA Nuclear Medicine/Radiopharmaceutic Revenue Market Share Regions in 2016
Table EMEA Nuclear Medicine/Radiopharmaceutic Sales Price (USD/Kg) by Region (2012-2017)
Figure Europe Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate (2012-2017)
Figure Europe Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2012-2017)
Table Europe Nuclear Medicine/Radiopharmaceutic Sales (MT) by Type (2012-2017)
Table Europe Nuclear Medicine/Radiopharmaceutic Market Share by Type (2012-2017)
Figure Europe Nuclear Medicine/Radiopharmaceutic Market Share by Type in 2016
Table Europe Nuclear Medicine/Radiopharmaceutic Sales (MT) by Application (2012-2017)
Table Europe Nuclear Medicine/Radiopharmaceutic Market Share by Application (2012-2017)
Figure Europe Nuclear Medicine/Radiopharmaceutic Market Share by Application in 2016
Table Europe Nuclear Medicine/Radiopharmaceutic Sales (MT) by Countries (2012-2017)
Table Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries (2012-2017)
Figure Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries (2012-2017)
Figure Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries in 2016
Table Europe Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) by Countries (2012-2017)
Table Europe Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries (2012-2017)
Figure Europe Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries (2012-2017)
Figure Europe Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries in 2016
Figure Germany Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate (2012-2017)
Figure France Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate (2012-2017)
Figure UK Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate (2012-2017)
Figure Russia Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate (2012-2017)
Figure Italy Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate (2012-2017)
Figure Benelux Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate (2012-2017)
Figure Middle East Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate (2012-2017)
Figure Middle East Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Nuclear Medicine/Radiopharmaceutic Sales (MT) by Type (2012-2017)
Table Middle East Nuclear Medicine/Radiopharmaceutic Market Share by Type (2012-2017)
Figure Middle East Nuclear Medicine/Radiopharmaceutic Market Share by Type (2012-2017)
Table Middle East Nuclear Medicine/Radiopharmaceutic Sales (MT) by Applications (2012-2017)
Table Middle East Nuclear Medicine/Radiopharmaceutic Market Share by Applications (2012-2017)
Figure Middle East Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application in 2016
Table Middle East Nuclear Medicine/Radiopharmaceutic Sales Volume (MT) by Countries (2012-2017)
Table Middle East Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Countries in 2016
Table Middle East Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) by Countries (2012-2017)
Table Middle East Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries (2012-2017)
Figure Middle East Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries (2012-2017)
Figure Middle East Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries in 2016
Figure Saudi Arabia Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate (2012-2017)
Figure Israel Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate (2012-2017)
Figure UAE Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate (2012-2017)
Figure Iran Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate (2012-2017)
Figure Africa Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate (2012-2017)
Figure Africa Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Nuclear Medicine/Radiopharmaceutic Sales (MT) by Type (2012-2017)
Table Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2012-2017)
Figure Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2012-2017)
Figure Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type in 2016
Table Africa Nuclear Medicine/Radiopharmaceutic Sales (MT) by Application (2012-2017)
Table Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2012-2017)
Figure Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2012-2017)
Table Africa Nuclear Medicine/Radiopharmaceutic Sales Volume (MT) by Countries (2012-2017)
Table Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries (2012-2017)
Figure Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries (2012-2017)
Figure Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries in 2016
Table Africa Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) by Countries (2012-2017)
Table Africa Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries (2012-2017)
Figure Africa Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries (2012-2017)
Figure Africa Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries in 2016
Figure South Africa Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate (2012-2017)
Figure Nigeria Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate (2012-2017)
Figure Egypt Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate (2012-2017)
Figure Algeria Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate (2012-2017)
Table China Isotope Radiation Nuclear Medicine/Radiopharmaceutic Basic Information List
Table China Isotope Radiation Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure China Isotope Radiation Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate (2012-2017)
Figure China Isotope Radiation Nuclear Medicine/Radiopharmaceutic Sales Market Share in EMEA (2012-2017)
Figure China Isotope Radiation Nuclear Medicine/Radiopharmaceutic Revenue Market Share in EMEA (2012-2017)
Table Dongcheng Nuclear Medicine/Radiopharmaceutic Basic Information List
Table Dongcheng Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Dongcheng Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate (2012-2017)
Figure Dongcheng Nuclear Medicine/Radiopharmaceutic Sales Market Share in EMEA (2012-2017)
Figure Dongcheng Nuclear Medicine/Radiopharmaceutic Revenue Market Share in EMEA (2012-2017)
Table Jaco Nuclear Medicine/Radiopharmaceutic Basic Information List
Table Jaco Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Jaco Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate (2012-2017)
Figure Jaco Nuclear Medicine/Radiopharmaceutic Sales Market Share in EMEA (2012-2017)
Figure Jaco Nuclear Medicine/Radiopharmaceutic Revenue Market Share in EMEA (2012-2017)
Table Ciaeriar Nuclear Medicine/Radiopharmaceutic Basic Information List
Table Ciaeriar Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Ciaeriar Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate (2012-2017)
Figure Ciaeriar Nuclear Medicine/Radiopharmaceutic Sales Market Share in EMEA (2012-2017)
Figure Ciaeriar Nuclear Medicine/Radiopharmaceutic Revenue Market Share in EMEA (2012-2017)
Table Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceutic Basic Information List
Table Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate (2012-2017)
Figure Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceutic Sales Market Share in EMEA (2012-2017)
Figure Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceutic Revenue Market Share in EMEA (2012-2017)
Table Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceutic Basic Information List
Table Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate (2012-2017)
Figure Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceutic Sales Market Share in EMEA (2012-2017)
Figure Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceutic Revenue Market Share in EMEA (2012-2017)
Table Cardinal Health Nuclear Medicine/Radiopharmaceutic Basic Information List
Table Cardinal Health Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Cardinal Health Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate (2012-2017)
Figure Cardinal Health Nuclear Medicine/Radiopharmaceutic Sales Market Share in EMEA (2012-2017)
Figure Cardinal Health Nuclear Medicine/Radiopharmaceutic Revenue Market Share in EMEA (2012-2017)
Table Mallinckrodt Nuclear Medicine/Radiopharmaceutic Basic Information List
Table Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate (2012-2017)
Figure Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales Market Share in EMEA (2012-2017)
Figure Mallinckrodt Nuclear Medicine/Radiopharmaceutic Revenue Market Share in EMEA (2012-2017)
Table GE Healthcare Nuclear Medicine/Radiopharmaceutic Basic Information List
Table GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate (2012-2017)
Figure GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales Market Share in EMEA (2012-2017)
Figure GE Healthcare Nuclear Medicine/Radiopharmaceutic Revenue Market Share in EMEA (2012-2017)
Table Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Basic Information List
Table Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate (2012-2017)
Figure Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales Market Share in EMEA (2012-2017)
Figure Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Revenue Market Share in EMEA (2012-2017)
Table Bayer Healthcare Nuclear Medicine/Radiopharmaceutic Basic Information List
Table Bracco Imaging Nuclear Medicine/Radiopharmaceutic Basic Information List
Table Eczacibasi-Monrol Nuclear Products Nuclear Medicine/Radiopharmaceutic Basic Information List
Table Nordion Nuclear Medicine/Radiopharmaceutic Basic Information List
Table Advanced Accelerator Applications Nuclear Medicine/Radiopharmaceutic Basic Information List
Table Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nuclear Medicine/Radiopharmaceutic
Figure Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceutic
Figure Nuclear Medicine/Radiopharmaceutic Industrial Chain Analysis
Table Raw Materials Sources of Nuclear Medicine/Radiopharmaceutic Major Manufacturers in 2016
Table Major Buyers of Nuclear Medicine/Radiopharmaceutic
Table Distributors/Traders List
Figure EMEA Nuclear Medicine/Radiopharmaceutic Sales (MT) and Growth Rate Forecast (2017-2022)
Figure EMEA Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Nuclear Medicine/Radiopharmaceutic Price (USD/Kg) and Trend Forecast (2017-2022)
Table EMEA Nuclear Medicine/Radiopharmaceutic Sales (MT) Forecast by Region (2017-2022)
Figure EMEA Nuclear Medicine/Radiopharmaceutic Sales Market Share Forecast by Region (2017-2022)
Table EMEA Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Nuclear Medicine/Radiopharmaceutic Revenue Market Share Forecast by Region (2017-2022)
Table Europe Nuclear Medicine/Radiopharmaceutic Sales (MT) Forecast by Countries (2017-2022)
Figure Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share Forecast by Countries (2017-2022)
Table Europe Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Nuclear Medicine/Radiopharmaceutic Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Nuclear Medicine/Radiopharmaceutic Sales (MT) Forecast by Countries (2017-2022)
Figure Middle East Nuclear Medicine/Radiopharmaceutic Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Nuclear Medicine/Radiopharmaceutic Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Nuclear Medicine/Radiopharmaceutic Sales (MT) Forecast by Countries (2017-2022)
Figure Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share Forecast by Countries (2017-2022)
Table Africa Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Nuclear Medicine/Radiopharmaceutic Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Nuclear Medicine/Radiopharmaceutic Sales (MT) Forecast by Type (2017-2022)
Figure EMEA Nuclear Medicine/Radiopharmaceutic Sales Market Share Forecast by Type (2017-2022)
Table EMEA Nuclear Medicine/Radiopharmaceutic Sales (MT) Forecast by Application (2017-2022)
Figure EMEA Nuclear Medicine/Radiopharmaceutic Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources